(Q30455725)

21 June 2017

A multi-institutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma (English)

1 reference

21 June 2017

uterine carcinosarcoma

1 reference

David E Cohn

8

0 references

Laura J. Havrilesky

2

object named as

Laura Havrilesky

1 reference

21 June 2017

Angeles Alvarez Secord

6

object named as

Angeles Alvarez Secord

1 reference

21 June 2017

7

Christa I Nagel

1 reference

21 June 2017

9

Amanda Nickles Fader

1 reference

21 June 2017

12

Paola A Gehrig

1 reference

21 June 2017

Leigh A Cantrell

1

1 reference

21 June 2017

Dominic T Moore

3

1 reference

21 June 2017

David O'Malley

4

1 reference

21 June 2017

Margaret Liotta

5

1 reference

21 June 2017

Amy H Wallace

10

1 reference

21 June 2017

Peter Rose

11

1 reference

21 June 2017

language of work or name

English

0 references

publication date

20 June 2012

1 reference

21 June 2017

1 reference

21 June 2017

127

1 reference

21 June 2017

1

1 reference

21 June 2017

22-26

1 reference

21 June 2017

Uterine carcinosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Uterine Neoplasms. Clinical Practice Guidelines in Oncology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Out of India, thrice: diversification of Asian forest scorpions reveals three colonizations of Southeast Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Grip-force modulation in human-to-human object handovers: effects of sensory and kinematic manipulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

The impact of multi-modal therapy on survival for uterine carcinosarcomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.06.020

10.1016/J.YGYNO.2012.06.020

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference